JBCHEPHARMNSEJB Chemicals & Pharmaceuticals Limited· PharmaceuticalsHighNeutral
Announced Fri, 20 Feb · 22:40 IST

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot

Ceo Appointed ExternalPromoter Family Board EntryManagement Changes View source PDF

JBCHEPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

JB Chemicals has sent a Postal Ballot Notice to shareholders seeking approval for five key board appointments through remote e-voting (Feb 22 to Mar 23, 2026, results by Mar 25, 2026). The most significant item is the appointment of Mr. Aman Mehta, age 34, currently the Managing Director of Torrent Pharmaceuticals Limited, as Director and then as Managing Director of JB Chemicals for 3 years effective January 21, 2026, without any remuneration. Three Torrent Pharma executives are also proposed as Non-Executive Non-Independent Directors: Mr. Amal Kelshikar (58, heads Torrent's India business), Mr. Hasmukh Patel (57, COO of Torrent Pharma), and Mr. Sudhir Menon. All appointees were initially brought on as Additional Directors on January 21, 2026, and now need shareholder ratification.

Likely market impact

This signals a major management change with Torrent Pharmaceuticals' MD taking the top job at JB Chemicals, indicating Torrent's deepening control over the company. The Mehta family (promoters of Torrent) is now placing senior Torrent executives across JB Chemicals' board, which could reshape strategy and operations for shareholders.